Genmab

	15/9 18:10 af Solsen	Much more potent than first line I/O - med PD-L1 x 4-1BB. Det lyder vildt !
	15/9 18:09 af nohope	Ok, glæder mig til de går til kun at regne i MIA
	15/9 18:08 af Solsen	Tak
	15/9 18:07 af Solsen	Mln - med Genmab regner man kun i millioner :-)
	15/9 18:05 af nohope	150$ ?Er det sådan et symbolsk beløb ?
	15/9 18:01 af Solsen	Hexa38 10-100 gange mere potent end dara. JNJ skal betale $150 for at overtage og 20% flat royalty. Var det virkelig doller ?
	15/9 17:45 af Solsen	Ser ud til man kan sende spørgsmål. PI er i front :-)
	15/9 16:27 af gdn55	Det kan vi da håbe på.
	15/9 16:20 af Solsen	Horizon har sat ny ATH i dag... mon ikke Genmab også snart gør et forsøg :-)
	15/9 16:14 af GeorgeBest	Freindly reminder: Fireside Chat with President and CEO, Jan van de Winkel and Executive Vice President and Chief Financial Officer, Anthony Pagano 17:45 (link)
	15/9 12:05 af E L	the french estimate a maximum of 7,900 Dara patients in the SC reimbursement document (link) pdf p43
	15/9 11:56 af E L	lol
	15/9 11:45 af Plimsoller	Big market if they don't copy it :-)
	15/9 11:44 af E L	i guess that makes sense. you can see in clinicaltrials that they are looking to add a lot of chinese hospitals in the trials, only the first PhI has some recruiting there already
	15/9 11:35 af Plimsoller	Just elaborating after she had a second look. it says that the company got persmission from the government to perform the trials. It basically means that the company must have submitted the request to the government bureau beforehand.
	15/9 11:26 af E L	haha
	15/9 11:26 af Plimsoller	:-)
	15/9 11:26 af Plimsoller	No problem. She is quite impressed that a Dutch guy who doesn't speak Chinese found that article :D
	15/9 11:25 af E L	ok, thanks. and thanks to your colleague ;-)
	15/9 11:24 af Plimsoller	Yes.
	15/9 11:23 af E L	permission for what ? to do the trial?
	15/9 11:22 af Plimsoller	I used Google myself (thought you had issued with their translator), but I just asked a Chinese colleague that question, and she said that they are saying that they have permission.
	15/9 11:18 af E L	Did they get permission to do those 4 trials in China ? is that what they are saying?
	15/9 11:17 af E L	thanks, got them, similar to what i get with google tranlator, however wasn't sure what that actually means?

	15/9 11:13 af Plimsoller	That didn't go to well :-) Hang on - will send you another one.
	15/9 11:07 af Plimsoller	Sent you a PM E L.
	15/9 10:34 af E L	could use some help on the translation of this chinese article on Amivantamab... (link)
	15/9 09:50 af Helge Larsen/PI-redaktør	Yes. :-)
	15/9 09:28 af E L	ok. I guess we find out next week ;-)
	15/9 09:27 af Helge Larsen/PI-redaktør	I receive Symphony Health data from pharma- og biotech investors. I dont know anything about af a evnt. split in Dara IV and Dara Faspro.
	15/9 09:21 af Helge Larsen/PI-redaktør	Sorry..Link to tweet. (link)
	15/9 09:16 af E L	I was just wondering Helge, I don't know who you normally get the Symphony Health data from, but should we expect 1 number for Dara, or a split in Dara IV and Dara Faspro?
	15/9 09:14 af E L	that link doesn't get you much, you may want to put the link to the tweet?
	15/9 09:11 af Helge Larsen/PI-redaktør	Genmab @Genmab Join us at ESMO20, for an oral presentation on phase 2 innovaTV 204 study evaluating the investigational tisotumab vedotin in patients with recurrent or metastatic #cervicalcancer. Visit our virtual booth to get more info. (link)
	15/9 08:05 af transalp	Go morgen.. :)
	15/9 06:55 af bibob	God morgen :-)
	15/9 06:49 af Helge Larsen/PI-redaktør	God morgen. :-)
	14/9 19:45 af GeorgeBest	og igen side 66-68 / Roche har fart på, SC version præsenteres på ASH!
	14/9 19:42 af GeorgeBest	Mosunetuzumab and glofitamab (CD20xCD3) Potential first in class bispecifics in DLBCL and FL - se side 44 (link)
	14/9 19:41 af Helge Larsen/PI-redaktør	amyloidosis Research Consortium @Amyloidosis_ARC · 3 t Game changer for AL amyloidosis -Janssen Pharmaceutical has filed an application with the US Food and Drug Administration seeking approval for Darzalex Faspro to treat light chain (AL) amyloidosis. (link)
	14/9 19:40 af GeorgeBest	Roche Pharma Day 2020 presentation (link)
	14/9 17:51 af Solsen	Vi ved at JW har ambition om at blive et stort pharma med Genmab a la Regeneron eller Amgen. Hhv $60 og $145 bn....
	14/9 16:27 af Solsen	Godt vi så ved at JW siger, at I ikke skal sælge ;-)
	14/9 16:11 af nohope	Ja, eller 2200
	14/9 15:21 af Solsen	...deals
	14/9 14:53 af Solsen	More ADC reals - SGEN and Merck (link)
	14/9 13:38 af Helge Larsen/PI-redaktør	Stockbull...Jeg tænker ud fra citatet ikke på aktiemarkedet, men alene realøkonomien.
	14/9 13:20 af E L	SpringWorks already works with GSK on belantamab
	14/9 13:17 af E L	(link)
	14/9 13:16 af E L	SpringWorks Therapeutics Announces Clinical Collaboration with Janssen to Evaluate Nirogacestat in Combination with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma